CD79A and ganglioneuroma: Furthermore, though the quantity of serum HBV-related antigens exacerbate HBV-GN by increasing the deposition of HBV-related antigens, IgA, IgG, IgM, and complement in the glomeruli,[8] the current treatment modalities for HBV infection hardly eliminate HBsAg.